Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 2/20 | 0.33 |
| ▸ | UGCG | Q16739 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10136243 | 0.95 | ALDH1A1 (0.40) | ALDH1A1DHODHHTR6UGCGLMNA | |
| SCHEMBL10136606 | 0.94 | HTR6 (0.37) | ALDH1A1HTR6LMNANTRK1KCNH2 | |
| SCHEMBL10118322 | 0.92 | ALDH1A1 (0.35) | ALDH1A1DHODHHTR6LMNAELANE | |
| SCHEMBL10136612 | 0.92 | ALDH1A1 (0.35) | ALDH1A1DHODHHTR6UGCGLMNA | |
| SCHEMBL10136867 | 0.91 | DHODH (0.34) | ALDH1A1DHODHUGCGNTRK1CYP3A4 | |
| SCHEMBL10136626 | 0.90 | POLB (0.37) | ALDH1A1DHODHHTR6LMNAELANE | |
| SCHEMBL10136313 | 0.90 | HTR6 (0.36) | ALDH1A1DHODHHTR6LMNANTRK1 | |
| SCHEMBL10136248 | 0.90 | LMNA (0.41) | ALDH1A1HTR6LMNANTRK1 | |
| SCHEMBL10136642 | 0.89 | ALDH1A1 (0.35) | ALDH1A1DHODHUGCGCYP3A4MRGPRX4 | |
| SCHEMBL10136641 | 0.89 | ALDH1A1 (0.34) | ALDH1A1DHODHUGCGCYP3A4ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791139-B2 | Anthranilic diamide derivatives | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | DDT, QDPR, ANTXR2 | ALDH1A1 732/4885DHODH 197/4885HTR6 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.